The components and regulation of the Hippo pathway and its relationships with the progression and treatment of Non-small cell lung cancer (NSCLC)
Abstract Background Lung cancer is one of the most common malignant tumours, with non-small cell lung cancer (NSCLC) being the predominant type. The morbidity and mortality rates of lung cancer are increasing worldwide. The Hippo signalling pathway is one of the eight classical human cancer signalli...
Saved in:
| Main Authors: | Yuheng Feng, Xueting Gan, Xuezhu Rong, Qiang Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03946-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Hippo Pathway in Kidney Development
by: Caroline M. Lara, et al.
Published: (2025-01-01) -
Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease
by: Wei Xuan, et al.
Published: (2025-01-01) -
CDK5 interacts with MST2 and modulates the Hippo signalling pathway
by: Mehak Passi, et al.
Published: (2025-04-01) -
Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders
by: Juanjuan Han, et al.
Published: (2024-10-01) -
Exploring the Revolutionary Impact of YAP Pathways on Physical and Rehabilitation Medicine
by: Carmelo Pirri
Published: (2025-01-01)